Published in Am J Gastroenterol on January 06, 2009
American Gastroenterological Association technical review on the management of Barrett's esophagus. Gastroenterology (2011) 2.50
Efficacy and durability of radiofrequency ablation for Barrett's Esophagus: systematic review and meta-analysis. Clin Gastroenterol Hepatol (2013) 2.28
Development of subsquamous high-grade dysplasia and adenocarcinoma after successful radiofrequency ablation of Barrett's esophagus. Gastroenterology (2012) 1.94
The case for endoscopic treatment of non-dysplastic and low-grade dysplastic Barrett's esophagus. Dig Dis Sci (2010) 1.65
Surveillance for low-grade dysplastic Barrett's oesophagus: one size fits all? World J Surg (2015) 1.45
Incidence and predictors of adenocarcinoma following endoscopic ablation of Barrett's esophagus. Dig Dis Sci (2014) 1.44
Preference of endoscopic ablation over medical prevention of esophageal adenocarcinoma by patients with Barrett's esophagus. Clin Gastroenterol Hepatol (2014) 1.40
Predictors of progression in Barrett's esophagus: current knowledge and future directions. Am J Gastroenterol (2010) 1.35
Statins are associated with reduced risk of esophageal cancer, particularly in patients with Barrett's esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol (2013) 1.29
Safety of prior endoscopic mucosal resection in patients receiving radiofrequency ablation of Barrett's esophagus. Clin Gastroenterol Hepatol (2011) 1.22
Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma. Gastroenterology (2015) 1.21
Treatment of ultralong-segment Barrett's using focal and balloon-based radiofrequency ablation. Surg Endosc (2009) 1.20
Incidence of Esophageal Adenocarcinoma and Causes of Mortality After Radiofrequency Ablation of Barrett's Esophagus. Gastroenterology (2015) 1.11
Quality Indicators for the Management of Barrett's Esophagus, Dysplasia, and Esophageal Adenocarcinoma: International Consensus Recommendations from the American Gastroenterological Association Symposium. Gastroenterology (2015) 1.01
Biomarkers in Barrett's esophagus and esophageal adenocarcinoma: predictors of progression and prognosis. World J Gastroenterol (2010) 0.98
Barrett's oesophagus: Evidence from the current meta-analyses. World J Gastrointest Pathophysiol (2014) 0.82
Cerenkov Radiation Induced Photodynamic Therapy Using Chlorin e6-Loaded Hollow Mesoporous Silica Nanoparticles. ACS Appl Mater Interfaces (2016) 0.80
Obesity-Related Digestive Diseases and Their Pathophysiology. Gut Liver (2016) 0.78
Diagnosis and management of Barrett's esophagus. Surg Clin North Am (2012) 0.78
Endoscopic management of Barrett's esophagus: advances in endoscopic techniques. Dig Dis Sci (2012) 0.78
Mucosal ablation of Barrett esophagus. Nat Rev Gastroenterol Hepatol (2009) 0.77
GERD-Barrett-Adenocarcinoma: Do We Have Suitable Prognostic and Predictive Molecular Markers? Gastroenterol Res Pract (2013) 0.77
Risk factors associated with Barrett's epithelial dysplasia. World J Gastroenterol (2014) 0.77
Management of Barrett's oesophagus and intramucosal oesophageal cancer: a review of recent development. Therap Adv Gastroenterol (2012) 0.76
Radiofrequency ablation of Barrett's esophagus: let's not get ahead of ourselves. Dig Dis Sci (2010) 0.76
High-grade dysplasia and intramucosal adenocarcinoma in Barrett's esophagus: the role of endoscopic eradication therapy. Curr Opin Gastroenterol (2012) 0.76
The incidence of esophageal adenocarcinoma in Barrett's esophagus has been overestimated. Am J Gastroenterol (2011) 0.76
Changes in gene expression of neo-squamous mucosa after endoscopic treatment for dysplastic Barrett's esophagus and intramucosal adenocarcinoma. United European Gastroenterol J (2016) 0.75
Managing Barrett's esophagus with radiofrequency ablation. Gastroenterol Rep (Oxf) (2013) 0.75
Endoscopic resection of barrett esophagus with high-grade dysplasia and early esophageal cancer. Gastroenterol Hepatol (N Y) (2010) 0.75
Diagnosis and management of Barrett's metaplasia: What's new. World J Gastrointest Endosc (2012) 0.75
Evolving management of metaplasia and dysplasia in Barrett's epithelium. World J Gastroenterol (2016) 0.75
Esophageal diseases. Gastrointest Endosc (2014) 0.75
Low risk of adenocarcinoma and high-grade dysplasia in patients with non-dysplastic Barrett's esophagus: Results from a cohort from a country with low esophageal adenocarcinoma incidence. United European Gastroenterol J (2015) 0.75
Oral steroid prophylaxis is effective in preventing esophageal strictures after large endoscopic resection. Ann Gastroenterol (2016) 0.75
Surgery for cystic pancreatic lesions in the post-sendai era: a single institution experience. HPB Surg (2015) 0.75
The new kid on the block for advanced imaging in Barrett's esophagus: a review of volumetric laser endomicroscopy. Therap Adv Gastroenterol (2016) 0.75
Low grade dysplasia in Barrett's esophagus: Should we worry? World J Gastrointest Pathophysiol (2014) 0.75
Esophageal diseases. Endoscopy (2014) 0.75
Progression of Barrett's esophagus toward esophageal adenocarcinoma: an overview. Ann Gastroenterol (2016) 0.75
Treatment of GERD complications (Barrett's, peptic stricture) and extra-oesophageal syndromes. Best Pract Res Clin Gastroenterol (2010) 0.75
Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol (2011) 12.48
Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med (2009) 10.91
Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology (2012) 7.15
Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission. Sci Transl Med (2011) 6.79
American Gastroenterological Association medical position statement on the management of Barrett's esophagus. Gastroenterology (2011) 5.93
Quality indicators for colonoscopy. Gastrointest Endosc (2014) 4.17
Esophageal dilation in eosinophilic esophagitis: safety and predictors of clinical response and complications. Gastrointest Endosc (2010) 3.74
A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. Gastroenterology (2004) 3.50
Durability of radiofrequency ablation in Barrett's esophagus with dysplasia. Gastroenterology (2011) 3.44
Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry. Gastrointest Endosc (2008) 3.13
Variability in diagnostic criteria for eosinophilic esophagitis: a systematic review. Am J Gastroenterol (2007) 2.94
American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease. Gastroenterology (2008) 2.79
Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis. Gastrointest Endosc (2007) 2.77
The utility of a novel narrow band imaging endoscopy system in patients with Barrett's esophagus. Gastrointest Endosc (2006) 2.71
Diagnostic utility of major basic protein, eotaxin-3, and leukotriene enzyme staining in eosinophilic esophagitis. Am J Gastroenterol (2012) 2.70
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology (2012) 2.68
Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease. Clin Gastroenterol Hepatol (2009) 2.53
Endoscopic features of sessile serrated adenomas: validation by international experts using high-resolution white-light endoscopy and narrow-band imaging. Gastrointest Endosc (2013) 2.53
The American Society for Gastrointestinal Endoscopy PIVI (Preservation and Incorporation of Valuable Endoscopic Innovations) on real-time endoscopic assessment of the histology of diminutive colorectal polyps. Gastrointest Endosc (2011) 2.51
Real-time increased detection of neoplastic tissue in Barrett's esophagus with probe-based confocal laser endomicroscopy: final results of an international multicenter, prospective, randomized, controlled trial. Gastrointest Endosc (2011) 2.51
American Gastroenterological Association technical review on the management of Barrett's esophagus. Gastroenterology (2011) 2.50
Influence of race and gender on the presentation of eosinophilic esophagitis. Am J Gastroenterol (2011) 2.47
Effect of a retrograde-viewing device on adenoma detection rate during colonoscopy: the TERRACE study. Gastrointest Endosc (2010) 2.38
Efficacy and durability of radiofrequency ablation for Barrett's Esophagus: systematic review and meta-analysis. Clin Gastroenterol Hepatol (2013) 2.28
Component Level Modular Design of a Solid State X-ray Image Intensifier for an M×N Array. IEEE Nucl Sci Symp Conf Rec (1997) (2010) 2.28
Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus. Gastroenterology (2011) 2.27
Water quality modelling of the river Yamuna (India) using QUAL2E-UNCAS. J Environ Manage (2006) 2.27
Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma. Clin Gastroenterol Hepatol (2010) 2.24
American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease. Gastroenterology (2008) 2.23
Digestive and liver diseases statistics, 2004. Gastroenterology (2004) 2.14
Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection. PLoS Med (2009) 2.11
Advanced imaging technologies increase detection of dysplasia and neoplasia in patients with Barrett's esophagus: a meta-analysis and systematic review. Clin Gastroenterol Hepatol (2013) 2.10
Quality indicators for colonoscopy. Am J Gastroenterol (2014) 2.06
Nonalcoholic fatty liver is not associated with incident chronic kidney disease: a large histology-based comparison with healthy individuals. Eur J Gastroenterol Hepatol (2016) 2.06
A cost-utility analysis of ablative therapy for Barrett's esophagus. Gastroenterology (2009) 1.95
Narrow-band imaging colonoscopy--a pilot feasibility study for the detection of polyps and correlation of surface patterns with polyp histologic diagnosis. Gastrointest Endosc (2007) 1.95
Correlation between narrow band imaging and nonneoplastic gastric pathology: a pilot feasibility trial. Gastrointest Endosc (2008) 1.85
Pancreatic stents for prophylaxis against post-ERCP pancreatitis: a meta-analysis and systematic review. Gastrointest Endosc (2011) 1.85
Overutilization of endoscopic surveillance in nondysplastic Barrett's esophagus: a multicenter study. Gastrointest Endosc (2011) 1.82
Endoscopic spray cryotherapy for esophageal cancer: safety and efficacy. Gastrointest Endosc (2010) 1.79
Bowel preparation with split-dose polyethylene glycol before colonoscopy: a meta-analysis of randomized controlled trials. Gastrointest Endosc (2011) 1.75
Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study. Am J Gastroenterol (2013) 1.75
Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis. Am J Gastroenterol (2003) 1.73
Persistence of nondysplastic Barrett's esophagus identifies patients at lower risk for esophageal adenocarcinoma: results from a large multicenter cohort. Gastroenterology (2013) 1.72
Detection of Barrett's esophagus after endoscopic healing of erosive esophagitis. Am J Gastroenterol (2006) 1.72
Inter- and intraobserver reliability and validation of a new method for determination of eosinophil counts in patients with esophageal eosinophilia. Dig Dis Sci (2009) 1.70
Single and multiple dose pharmacokinetics of maraviroc in saliva, semen, and rectal tissue of healthy HIV-negative men. J Infect Dis (2011) 1.70
Preliminary accuracy and interobserver agreement for the detection of intraepithelial neoplasia in Barrett's esophagus with probe-based confocal laser endomicroscopy. Gastrointest Endosc (2010) 1.69
Focal endoscopic mucosal resection before radiofrequency ablation is equally effective and safe compared with radiofrequency ablation alone for the eradication of Barrett's esophagus with advanced neoplasia. Gastrointest Endosc (2012) 1.67
A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus. Nat Genet (2013) 1.67
Cyclophosphamide disrupts hepatic sinusoidal endothelium and improves transplanted cell engraftment in rat liver. Hepatology (2002) 1.66
Reduced polyp detection as endoscopy shift progresses: experience with screening colonoscopy at a tertiary-care hospital. J Clin Gastroenterol (2011) 1.66
Viscous topical is more effective than nebulized steroid therapy for patients with eosinophilic esophagitis. Gastroenterology (2012) 1.65
A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus. Cancer Res (2009) 1.65
The prevalence and diagnostic utility of endoscopic features of eosinophilic esophagitis: a meta-analysis. Clin Gastroenterol Hepatol (2012) 1.64
Accuracy of in vivo optical diagnosis of colon polyp histology by narrow-band imaging in predicting colonoscopy surveillance intervals. Gastrointest Endosc (2011) 1.61
Recognition of surface mucosal and vascular patterns of colon polyps by using narrow-band imaging: interobserver and intraobserver agreement and prediction of polyp histology. Gastrointest Endosc (2009) 1.60
Weight loss can lead to resolution of gastroesophageal reflux disease symptoms: a prospective intervention trial. Obesity (Silver Spring) (2013) 1.60
Accuracy of narrow-band imaging in predicting colonoscopy surveillance intervals and histology of distal diminutive polyps: results from a multicenter, prospective trial. Gastrointest Endosc (2013) 1.58
A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagus. Gastroenterology (2012) 1.58
Association between length of Barrett's esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia. Clin Gastroenterol Hepatol (2013) 1.56
Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus. Nat Genet (2012) 1.52
Nrf2 deficiency impairs the barrier function of mouse oesophageal epithelium. Gut (2013) 1.52
The impact of the changing health care environment on the health and well-being of faculty at four medical schools. Acad Med (2006) 1.50
High accuracy of narrow band imaging without magnification for the real-time characterization of polyp histology and its comparison with high-definition white light colonoscopy: a prospective study. Am J Gastroenterol (2009) 1.50
Early versus delayed feeding after placement of a percutaneous endoscopic gastrostomy: a meta-analysis. Am J Gastroenterol (2008) 1.50
A 25-year analysis of the American College of Gastroenterology research grant program: factors associated with publication and advancement in academics. Am J Gastroenterol (2009) 1.49
Esophageal foreign-body impactions: epidemiology, time trends, and the impact of the increasing prevalence of eosinophilic esophagitis. Gastrointest Endosc (2011) 1.49
Detection of dysplasia in Barrett's esophagus with in vivo depth-resolved nuclear morphology measurements. Gastroenterology (2010) 1.48
Barrett's esophagus and the costs of "doing something". Gastrointest Endosc (2007) 1.47
Feasibility, safety, acceptability, and yield of office-based, screening transnasal esophagoscopy (with video). Gastrointest Endosc (2012) 1.46
Higher adenoma detection rates with cap-assisted colonoscopy: a randomised controlled trial. Gut (2011) 1.45
A feasibility trial of narrow band imaging endoscopy in patients with gastroesophageal reflux disease. Gastroenterology (2007) 1.44